MedPath

Chlorphenesin

Generic Name
Chlorphenesin
Drug Type
Small Molecule
Chemical Formula
C9H11ClO3
CAS Number
104-29-0
Unique Ingredient Identifier
I670DAL4SZ

Overview

No overview information available.

Indication

Used, along with rest and physical therapy, to treat injuries and other painful muscular conditions. Investigated for use in trigeminal neuralgia (tic douloureux), a neuropathic disorder characterized by severe facial pain. Was investigated as a modulator of histamine release.

Associated Conditions

  • Muscle Spasms

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2021/10/19
Phase 1
Active, not recruiting
Changhoon Yoo

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
Z.S.C. Powder dusting powder
20355
Medicine
A
10/14/1991

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
MYCIL CREAM
allen & hanburys a glaxo canada ltd. co.
00253065
Cream - Topical
10 MG / G
12/31/1948
MYCIL POWDER 1%
roberts pharmaceutical canada inc.
02091496
Powder - Topical
1 %
7/30/1996
MYCIL CREAM 1%
02089637
Cream - Topical
1.0 %
4/30/1996
ANIVY
allen & hanburys a glaxo canada ltd. co.
00365343
Ointment - Topical
10 MG / G
3/23/1988
MYCIL POWDER
allen & hanburys a glaxo canada ltd. co.
00253073
Powder - Topical
10 MG / G
12/31/1951

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.